Stockscreener 앱 받기
4.29
5.92%
-0.27
전일 마감가:
$4.56
열려 있는:
$4.57
하루 거래량:
104.04K
Relative Volume:
0.34
시가총액:
$90.02M
수익:
-
순이익/손실:
$-94.11M
주가수익비율:
-0.7138
EPS:
-6.01
순현금흐름:
$-86.06M
1주 성능:
-10.81%
1개월 성능:
+48.96%
6개월 성능:
+46.42%
1년 성능:
-46.91%
1일 변동 폭
$4.23
$4.6184
1주일 범위
$4.10
$4.945
52주 변동 폭
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
명칭
Adverum Biotechnologies Inc
전화
(650) 649-1004
주소
100 CARDINAL WAY, REDWOOD CITY, CA
ADVM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
4.29 | 95.69M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2022-07-07 | 업그레이드 | Truist | Hold → Buy |
| 2021-07-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | 다운그레이드 | Truist | Buy → Hold |
| 2020-12-16 | 개시 | UBS | Neutral |
| 2020-11-12 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-05-05 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-16 | 개시 | SVB Leerink | Outperform |
| 2020-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-09-13 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-06-14 | 재개 | Raymond James | Mkt Perform |
| 2018-11-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | 다운그레이드 | SunTrust | Buy → Hold |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-08-30 | 개시 | SunTrust | Buy |
| 2018-02-15 | 재개 | Piper Jaffray | Overweight |
| 2017-10-12 | 개시 | Raymond James | Outperform |
모두보기
Adverum Biotechnologies Inc 주식(ADVM)의 최신 뉴스
What’s the recovery path for long term holders of Adverum Biotechnologies Inc.July 2025 Closing Moves & Weekly Chart Analysis and Guides - newser.com
Adverum Biotechnologies Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Using RSI to spot recovery in Adverum Biotechnologies Inc.July 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
Real time social sentiment graph for Adverum Biotechnologies Inc.2025 Earnings Surprises & Safe Entry Point Alerts - newser.com
Will Adverum Biotechnologies Inc. stock return to pre crisis levelsRisk Management & Smart Swing Trading Techniques - newser.com
Does Adverum Biotechnologies Inc. fit your quant trading modelRecession Risk & Daily Growth Stock Investment Tips - newser.com
Does Adverum Biotechnologies Inc. (AVU0) stock trade below intrinsic valueRisk Management & Technical Confirmation Alerts - newser.com
What MACD trends signal for Adverum Biotechnologies Inc. (AVU0) stock2025 Key Lessons & Growth Focused Entry Reports - newser.com
Analyzing recovery setups for Adverum Biotechnologies Inc. investorsShare Buyback & Real-Time Volume Spike Alerts - newser.com
Is Adverum Biotechnologies Inc. stock attractive for growth ETFs2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Can Adverum Biotechnologies Inc. (AVU0) stock sustain revenue momentumGap Up & Smart Allocation Stock Tips - newser.com
Price action breakdown for Adverum Biotechnologies Inc.2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
What drives Adverum Biotechnologies Inc stock priceMACD Histogram Signals & Double Or Triple Profits - earlytimes.in
Can Adverum Biotechnologies Inc. recover in the next quarterAnalyst Upgrade & Expert Curated Trade Setups - newser.com
Adverum Biotechnologies Inc.’s volatility index tracking explainedFed Meeting & High Conviction Trade Alerts - newser.com
Adverum Biotechnologies (NASDAQ:ADVM) Stock Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Visual trend scoring systems applied to Adverum Biotechnologies Inc.Market Sentiment Review & Long-Term Capital Growth Strategies - newser.com
Short interest data insights for Adverum Biotechnologies Inc.Earnings Overview Summary & Safe Entry Trade Signal Reports - newser.com
Adverum Biotechnologies' (ADVM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Is Adverum Biotechnologies Inc. (AVU0) stock a buy during volatile marketsGlobal Markets & Technical Buy Zone Confirmations - newser.com
Will Adverum Biotechnologies Inc. stock gain from lower inflationWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
Using data filters to optimize entry into Adverum Biotechnologies Inc.July 2025 Summary & Verified Technical Signals - newser.com
Adverum Biotechnologies Inc Stock Analysis and ForecastShort Interest Overview & Explosive Profit Potential - earlytimes.in
What technical models suggest about Adverum Biotechnologies Inc.’s comebackWeekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Should you wait for a breakout in Adverum Biotechnologies Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - newser.com
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Will Adverum Biotechnologies Inc. stock go up soon2025 AllTime Highs & Safe Capital Growth Tips - newser.com
After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by the recent gain - simplywall.st
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners may be pleased with recent gains after 28% loss over the past year - Yahoo Finance
Adverum Biotechnologies Inc (ADVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):